Hologic Inc (HOLX)

$76.01 +0.36 (0.48%)
Market Cap 16.97B
Revenue (ttm) 4.10B
Net Income (ttm) 565.70M
EPS (ttm) N/A
PE Ratio 17.68
Forward PE 16.84
Profit Margin 13.80%
Debt to Equity Ratio 0.48
Volume 102,025,600
Avg Vol 4,924,910
Day's Range N/A - N/A
Shares Out 223.25M
Stochastic %K 91%
Beta 0.70
Analysts Hold
Price Target $75.58

Company Profile

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, an...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 508 263 2900
Address:
250 Campus Drive, Marlborough, United States
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 22 at 7:54 PM
$HOLX RSI: 82.43, MACD: 0.1520 Vol: 0.27, MA20: 75.49, MA50: 75.31 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BreakoutsHappen
BreakoutsHappen Apr. 9 at 2:14 PM
Unusal Volume Today: $HOLX $CAR $SEE $AL
0 · Reply
NasdaqPulse
NasdaqPulse Apr. 9 at 12:17 PM
Hologic Goes Private in $18B Deal! 👉Click to view @NasdaqPulse for timely updates amid the volatility. Big moves in the healthcare space today! Hologic ($HOLX) is set to go private in an $18 billion acquisition by Blackstone ($BX) & TPG ($TPG). This game-changing deal marks a major shift as one of the biggest players in diagnostics, medical devices, and imaging steps into the hands of private equity. With rising demand for healthcare tech, this acquisition could mean a whole new direction for Hologic's growth. Investors are speculating about the future value and strategic impact on the company. Will it pay off? Time to watch closely! Thoughts? Can this push Hologic even higher, or is the private equity play the end of the road for this stock?
0 · Reply
DonCorleone77
DonCorleone77 Apr. 9 at 10:40 AM
$CASY $HOLX $BX Casey's General Stores to replace Hologic in S&P 500 at open on 4/9 Affiliates of Blackstone (BX) and TPG Global are acquiring Hologic (HOLX) in a deal expected to be completed on or about April 7.
0 · Reply
NasdaqPulse
NasdaqPulse Apr. 8 at 6:33 PM
Momentum is building fast around Datavault AI Inc — and the data narrative is getting harder to ignore. Pairing 4 exchange relaunches with a staggering $750M in signed tokenization contracts isn’t just progress… it’s infrastructure-level expansion. 👉Click to view @NasdaqPulse for timely updates amid the volatility. If this execution holds, we’re not talking about hype — we’re talking about real adoption + real capital flow. Watch how this plays across $QNCX, Hologic Inc ($HOLX), and $AMC — because when platforms scale like this, liquidity and attention tend to follow. Key question: is the market fully pricing in this level of tokenization growth yet? Early positioning here could matter more than ever.
0 · Reply
BreakoutsHappen
BreakoutsHappen Apr. 8 at 2:00 PM
Unusual Volume of the day: $HOLX $LGN $OS $AL
0 · Reply
StocktwitsNews
StocktwitsNews Apr. 7 at 3:53 AM
HOLX, KOS, MRVL Stocks Hit 52-Week Highs Today: What's Driving The Rally? $HOLX $KOS $MRVL $BX $NVDA https://stocktwits.com/news/equity/markets/holx-kos-mrvl-stocks-hit-52-week-highs-whats-driving-the-rally/cZJJgoYRIYU
0 · Reply
MinimalistKLine
MinimalistKLine Apr. 7 at 2:42 AM
Strategic Brief: $MRVL Option Anomalies—Betting on S&P 500 Inclusion Prior to the 5:15pm S&P 500 rebalancing announcement (projected to replace $HOLX), we observed aggressive late-day flows into $MRVL May $115 OTM Calls. This positioning reflects a tactical front-running of the "forced buying" effect inherent in passive index tracking. Given Marvell’s high eligibility ranking in market cap and profitability, these option strikes represent a high-gamma bet on the Index Committee’s decision. If confirmed, the resulting passive inflow could trigger a non-linear price appreciation in post-market sessions.
0 · Reply
DisneyPalaceTrades
DisneyPalaceTrades Apr. 7 at 1:11 AM
$HOLX buyout tomorrow?
1 · Reply
DonCorleone77
DonCorleone77 Apr. 6 at 11:53 PM
$CASY $HOLX $BX Casey's General Stores to replace Hologic in S&P 500 at open on 4/9 Affiliates of Blackstone (BX) and TPG Global are acquiring Hologic (HOLX) in a deal expected to be completed on or about April 7.
0 · Reply
Latest News on HOLX
New Evidence Backs Hologic's AI-Powered Mammography Technology for Detecting Challenging Cancers

Apr 20, 2026, 8:05 AM EDT - 6 days ago

New Evidence Backs Hologic's AI-Powered Mammography Technology for Detecting Challenging Cancers

Blackstone and TPG Complete Acquisition of Hologic

Apr 7, 2026, 9:10 AM EDT - 19 days ago

Blackstone and TPG Complete Acquisition of Hologic

Casey's General Stores Set to Join S&P 500; DigitalOcean Holdings to Join S&P MidCap 400; Broadstone Net Lease to Join S&P SmallCap 600

Apr 6, 2026, 5:51 PM EDT - 20 days ago

Casey's General Stores Set to Join S&P 500; DigitalOcean Holdings to Join S&P MidCap 400; Broadstone Net Lease to Join S&P SmallCap 600

BNL CASY DOCN

Hologic Chief Executive Officer Steve MacMillan to Retire Upon Close of Go-Private Transaction

Apr 6, 2026, 8:00 AM EDT - 20 days ago

Hologic Chief Executive Officer Steve MacMillan to Retire Upon Close of Go-Private Transaction

1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates

Mar 17, 2026, 8:00 AM EDT - 5 weeks ago

1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates

Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio

Feb 4, 2026, 8:15 AM EST - 2 months ago

Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio

Hologic Announces Financial Results for First Quarter of Fiscal 2026

Jan 29, 2026, 4:02 PM EST - 3 months ago

Hologic Announces Financial Results for First Quarter of Fiscal 2026

Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026

Jan 15, 2026, 7:00 PM EST - 3 months ago

Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026

Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening

Jan 13, 2026, 9:00 AM EST - 3 months ago

Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening

Hologic's AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams

Dec 16, 2025, 8:08 AM EST - 4 months ago

Hologic's AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams

New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration

Dec 2, 2025, 8:10 AM EST - 5 months ago

New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration

New Clinical Evidence on Hologic's AI-Powered Mammography Solutions Will Be Unveiled at RSNA

Nov 25, 2025, 8:08 AM EST - 5 months ago

New Clinical Evidence on Hologic's AI-Powered Mammography Solutions Will Be Unveiled at RSNA

Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking

Nov 12, 2025, 8:11 AM EST - 5 months ago

Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking

Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025

Nov 3, 2025, 4:01 PM EST - 6 months ago

Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025

Hologic Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc. - HOLX

Oct 22, 2025, 4:56 PM EDT - 6 months ago

Hologic Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc. - HOLX

Blackstone, TPG to Buy Hologic for Up to $18.3 Billion

Oct 21, 2025, 9:18 AM EDT - 6 months ago

Blackstone, TPG to Buy Hologic for Up to $18.3 Billion

BX TPG

Blackstone, TPG to acquire medical device maker Hologic in up to $18.3 billion deal

Oct 21, 2025, 8:48 AM EDT - 6 months ago

Blackstone, TPG to acquire medical device maker Hologic in up to $18.3 billion deal

BX TPG

Hologic to be Acquired by Blackstone and TPG for up to $79 per Share

Oct 21, 2025, 8:41 AM EDT - 6 months ago

Hologic to be Acquired by Blackstone and TPG for up to $79 per Share

Hologic Stock Rises as Report Says Blackstone and TPG in Advanced Takeover Talks

Oct 20, 2025, 7:55 AM EDT - 6 months ago

Hologic Stock Rises as Report Says Blackstone and TPG in Advanced Takeover Talks

BX TPG

Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025

Oct 2, 2025, 4:04 PM EDT - 7 months ago

Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025

Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis

Oct 2, 2025, 8:05 AM EDT - 7 months ago

Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis

New Survey Results Underscore the Need to #BustTheMyth About Mammograms

Sep 30, 2025, 8:15 AM EDT - 7 months ago

New Survey Results Underscore the Need to #BustTheMyth About Mammograms

Volition Signs Co-Marketing and Services Agreement with Hologic

Sep 29, 2025, 9:30 AM EDT - 7 months ago

Volition Signs Co-Marketing and Services Agreement with Hologic

VNRX

Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-Arm

Sep 29, 2025, 9:30 AM EDT - 7 months ago

Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-Arm

New Data on Hologic's AI-Powered Mammography Technology to Be Presented at EUSOBI

Sep 26, 2025, 8:00 AM EDT - 7 months ago

New Data on Hologic's AI-Powered Mammography Technology to Be Presented at EUSOBI

Blackstone and TPG revive interest in buying Hologic, source says

Sep 17, 2025, 4:41 PM EDT - 7 months ago

Blackstone and TPG revive interest in buying Hologic, source says

BX TPG

Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference

Sep 3, 2025, 4:02 PM EDT - 8 months ago

Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference

Hologic raises annual profit forecast on diagnostic and surgical demand

Jul 30, 2025, 6:06 PM EDT - 9 months ago

Hologic raises annual profit forecast on diagnostic and surgical demand

Hologic Announces Financial Results for Third Quarter of Fiscal 2025

Jul 30, 2025, 4:01 PM EDT - 9 months ago

Hologic Announces Financial Results for Third Quarter of Fiscal 2025

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025

Jul 2, 2025, 4:05 PM EDT - 10 months ago

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025

Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation

Jun 2, 2025, 11:03 AM EDT - 11 months ago

Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation

Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday?

May 27, 2025, 3:48 PM EDT - 11 months ago

Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday?

Hologic rejects $16 billion take-private proposal from TPG and Blackstone, Financial Times reports

May 27, 2025, 1:05 PM EDT - 11 months ago

Hologic rejects $16 billion take-private proposal from TPG and Blackstone, Financial Times reports

BX TPG

Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to Patients

May 22, 2025, 5:05 PM EDT - 1 year ago

Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to Patients

Hologic to Webcast Presentations at Upcoming Investor Conferences

May 13, 2025, 4:10 PM EDT - 1 year ago

Hologic to Webcast Presentations at Upcoming Investor Conferences

Medical equipment maker Hologic lowers annual profit forecast on tariff uncertainty

May 1, 2025, 6:58 PM EDT - 1 year ago

Medical equipment maker Hologic lowers annual profit forecast on tariff uncertainty

Hologic Announces Financial Results for Second Quarter of Fiscal 2025

May 1, 2025, 4:01 PM EDT - 1 year ago

Hologic Announces Financial Results for Second Quarter of Fiscal 2025

Cellulite Treatment Market Trends, Growth Opportunities and Shares 2025-2030; Featuring Key Players - Hologic (Cynosure), Merz Pharma, Syneron Medical, Zimmer Aesthetics & More

Apr 25, 2025, 4:25 AM EDT - 1 year ago

Cellulite Treatment Market Trends, Growth Opportunities and Shares 2025-2030; Featuring Key Players - Hologic (Cynosure), Merz Pharma, Syneron Medical, Zimmer Aesthetics & More

Groundbreaking New Data on Hologic's AI-Powered Mammography Technology to Be Presented at SBI

Apr 24, 2025, 8:10 AM EDT - 1 year ago

Groundbreaking New Data on Hologic's AI-Powered Mammography Technology to Be Presented at SBI

Hologic Details Environmental, Social and Governance Efforts — Including Expanded Environmental Ambitions — in New Sustainability Report

Apr 22, 2025, 8:08 AM EDT - 1 year ago

Hologic Details Environmental, Social and Governance Efforts — Including Expanded Environmental Ambitions — in New Sustainability Report

Wayde McMillan Elected to Hologic Board of Directors

Apr 4, 2025, 4:15 PM EDT - 1 year ago

Wayde McMillan Elected to Hologic Board of Directors

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025

Apr 3, 2025, 4:30 PM EDT - 1 year ago

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025

Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference

Feb 25, 2025, 8:15 AM EST - 1 year ago

Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference

Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software

Feb 20, 2025, 3:00 AM EST - 1 year ago

Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software

Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay

Feb 18, 2025, 8:08 AM EST - 1 year ago

Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay

Hologic cuts annual revenue forecast on weak demand for breast health products

Feb 5, 2025, 5:56 PM EST - 1 year ago

Hologic cuts annual revenue forecast on weak demand for breast health products

OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 22 at 7:54 PM
$HOLX RSI: 82.43, MACD: 0.1520 Vol: 0.27, MA20: 75.49, MA50: 75.31 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BreakoutsHappen
BreakoutsHappen Apr. 9 at 2:14 PM
Unusal Volume Today: $HOLX $CAR $SEE $AL
0 · Reply
NasdaqPulse
NasdaqPulse Apr. 9 at 12:17 PM
Hologic Goes Private in $18B Deal! 👉Click to view @NasdaqPulse for timely updates amid the volatility. Big moves in the healthcare space today! Hologic ($HOLX) is set to go private in an $18 billion acquisition by Blackstone ($BX) & TPG ($TPG). This game-changing deal marks a major shift as one of the biggest players in diagnostics, medical devices, and imaging steps into the hands of private equity. With rising demand for healthcare tech, this acquisition could mean a whole new direction for Hologic's growth. Investors are speculating about the future value and strategic impact on the company. Will it pay off? Time to watch closely! Thoughts? Can this push Hologic even higher, or is the private equity play the end of the road for this stock?
0 · Reply
DonCorleone77
DonCorleone77 Apr. 9 at 10:40 AM
$CASY $HOLX $BX Casey's General Stores to replace Hologic in S&P 500 at open on 4/9 Affiliates of Blackstone (BX) and TPG Global are acquiring Hologic (HOLX) in a deal expected to be completed on or about April 7.
0 · Reply
NasdaqPulse
NasdaqPulse Apr. 8 at 6:33 PM
Momentum is building fast around Datavault AI Inc — and the data narrative is getting harder to ignore. Pairing 4 exchange relaunches with a staggering $750M in signed tokenization contracts isn’t just progress… it’s infrastructure-level expansion. 👉Click to view @NasdaqPulse for timely updates amid the volatility. If this execution holds, we’re not talking about hype — we’re talking about real adoption + real capital flow. Watch how this plays across $QNCX, Hologic Inc ($HOLX), and $AMC — because when platforms scale like this, liquidity and attention tend to follow. Key question: is the market fully pricing in this level of tokenization growth yet? Early positioning here could matter more than ever.
0 · Reply
BreakoutsHappen
BreakoutsHappen Apr. 8 at 2:00 PM
Unusual Volume of the day: $HOLX $LGN $OS $AL
0 · Reply
StocktwitsNews
StocktwitsNews Apr. 7 at 3:53 AM
HOLX, KOS, MRVL Stocks Hit 52-Week Highs Today: What's Driving The Rally? $HOLX $KOS $MRVL $BX $NVDA https://stocktwits.com/news/equity/markets/holx-kos-mrvl-stocks-hit-52-week-highs-whats-driving-the-rally/cZJJgoYRIYU
0 · Reply
MinimalistKLine
MinimalistKLine Apr. 7 at 2:42 AM
Strategic Brief: $MRVL Option Anomalies—Betting on S&P 500 Inclusion Prior to the 5:15pm S&P 500 rebalancing announcement (projected to replace $HOLX), we observed aggressive late-day flows into $MRVL May $115 OTM Calls. This positioning reflects a tactical front-running of the "forced buying" effect inherent in passive index tracking. Given Marvell’s high eligibility ranking in market cap and profitability, these option strikes represent a high-gamma bet on the Index Committee’s decision. If confirmed, the resulting passive inflow could trigger a non-linear price appreciation in post-market sessions.
0 · Reply
DisneyPalaceTrades
DisneyPalaceTrades Apr. 7 at 1:11 AM
$HOLX buyout tomorrow?
1 · Reply
DonCorleone77
DonCorleone77 Apr. 6 at 11:53 PM
$CASY $HOLX $BX Casey's General Stores to replace Hologic in S&P 500 at open on 4/9 Affiliates of Blackstone (BX) and TPG Global are acquiring Hologic (HOLX) in a deal expected to be completed on or about April 7.
0 · Reply
RunnerSignals
RunnerSignals Apr. 6 at 6:43 PM
52 week highs rotation signal $NOK $HOLX $KOS $MRVL $SATL breakouts and holding on volume
0 · Reply
topstockalerts
topstockalerts Apr. 6 at 6:33 PM
A change to the S&P 500 may be imminent as Hologic is set to be acquired and taken private, creating an open slot in the index. Analysts expect a replacement to be announced soon, potentially triggering market moves among candidates. Leading contenders include Marvell Technology, Alnylam Pharmaceuticals, and Veeva Systems, all of which meet key eligibility criteria such as market capitalization, liquidity, and sector representation. Veeva, in particular, stands out for its strong float-adjusted liquidity ratio within the healthcare sector. Inclusion in the S&P 500 often drives increased demand for a stock, as index funds and ETFs are required to add the new constituent. As a result, potential entrants may see upward price momentum ahead of and following the announcement. $HOLX $SPX $MID $MRVL $LNG
0 · Reply
Annet_why_net
Annet_why_net Apr. 6 at 3:25 PM
$OSRH Biotech company with funding and an active NDA with Sinopharm (approx. $81B in annual revenue). The BCME Fund shall pay up to an additional $815,000,000 in milestone payments, payable directly to OSR Holdings, Inc., upon achievement of clinical, regulatory, and commercial milestones to be detailed in the Definitive Agreement. Milestone Design Principles: ● Milestones shall be primarily weighted toward clinical and regulatory achievements, including advancement through Phase 2 and Phase 3 development and regulatory approvals. ● Purely operational milestones (e.g. patient recruitment thresholds or trial initiation alone) shall be minimized and capped. ● The milestone schedule shall be consistent with industry-standard oncology licensing transactions, adjusted to reflect the Phase-2b-ready status of VXM01. $PFSA $SLNO $HOLX $ADTX
0 · Reply
Annet_why_net
Annet_why_net Apr. 6 at 3:16 PM
$OSRH 😄The price is locked in at $10 OSR Holdings, Inc. shall retain an option to issue up to $15,000,000 of OSRH common stock to the BCME Fund at a price of $10.00 per share, exercisable at OSRH’s sole discretion no earlier than six (6) months following execution of the definitive Global License Agreement (the “Equity Option”). $PFSA $SLNO $HOLX $ADTX
1 · Reply
Annet_why_net
Annet_why_net Apr. 6 at 2:52 PM
$OSRH $815M in non-dilutive financing with a $10 per share option😏 $PFSA $SLNO $HOLX $ADTX
0 · Reply
WhaleAndState
WhaleAndState Apr. 6 at 12:02 PM
$HOLX CEO retirement announced — stock at $75.65, market cap $16.9B. The filing contains no material detail beyond the headline. Leadership transition may create uncertainty; expect potential volatility.
0 · Reply
MaxProfitTrades
MaxProfitTrades Apr. 2 at 12:27 PM
$HOLX Bleed
0 · Reply
QuantInsider
QuantInsider Mar. 16 at 9:21 PM
Seeing some interesting action on $HOLX today About 1,971 ATM $75 puts for April and June got snapped up as sweeps April volume is way above previous open interest Looks like a big player hedging instead of a full-blown short setup Stock has been flat with no fresh news driving this Implied vols on these puts are super low They're cheap for hedging but don't offer much for selling premium Watch for a break below $75 with more put demand before jumping in Right now, just a signal to keep an eye on
0 · Reply
ZacksResearch
ZacksResearch Mar. 10 at 1:10 PM
$HOLX is up 20.7% over the past year, outpacing its industry’s 3.8% decline! 🚀 📈 GYN Surgical revenue rose 7.5% in constant currency, driven by MyoSure and Fluent device sales 🌍 International market expansion with minimally invasive solutions ⚔️ Competition from $MDT and $JNJ in the surgical arena Is Hologic a buy or a sell? Full analysis here 👉 https://www.zacks.com/stock/news/2881339/what-drives-hologics-gyn-surgical-strength-in-a-competitive-market?cid=sm-stocktwits-2-2881339-body-36689&ADID=SYND_STOCKTWITS_TWEET_2_2881339_BODY_36689
0 · Reply
ZacksResearch
ZacksResearch Mar. 10 at 12:10 PM
$HOLX expanding its grip on women’s health — and the tailwinds are building. Hologic is boosting its GYN Surgical reach through MyoSure, NovaSure, and Gynesonics as the global women's health devices market grows and demand for minimally invasive procedures rises. See what could power the next move 👉 https://www.zacks.com/stock/news/2881339/what-drives-hologics-gyn-surgical-strength-in-a-competitive-market?cid=sm-stocktwits-2-2881339-teaser-36682&ADID=SYND_STOCKTWITS_TWEET_2_2881339_TEASER_36682
0 · Reply
ZacksResearch
ZacksResearch Mar. 6 at 3:13 PM
$HOLX has climbed 17.4% in a year, outpacing its industry’s 4.2% drop! 🚀 🔬 Panther Fusion assays & Breast Cancer Index test show promise 📉 Still, watch out: Zacks Rank #4 (Sell) could signal caution Discover the full story here 👉 https://www.zacks.com/stock/news/2880130/hologics-diagnostics-strength-in-focus-is-more-upside-ahead?cid=sm-stocktwits-2-2880130-body-36302&ADID=SYND_STOCKTWITS_TWEET_2_2880130_BODY_36302
0 · Reply
ZacksResearch
ZacksResearch Mar. 6 at 2:13 PM
COVID test declines hitting $HOLX — but the real story might be the next growth wave. The Diagnostics unit is seeing lower COVID-19 testing demand, yet expansion of Panther Fusion, new assays, and the AI-driven Genius system are positioned to support long-term growth potential. See what could drive the next phase for the company 👉 https://www.zacks.com/stock/news/2880130/hologics-diagnostics-strength-in-focus-is-more-upside-ahead?cid=sm-stocktwits-2-2880130-teaser-36292&ADID=SYND_STOCKTWITS_TWEET_2_2880130_TEASER_36292
0 · Reply